In conclusion, the combination of TA and cisplatin significantly promotes lung cancer cell apoptosis, and one of the synergistic antitumor mechanisms is mediated via the PERK-ATF4-CHOP pathway. This evidence concerns the gene ATF4 and lung carcinoma.